These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis. Broadley SA; Vanags D; Williams B; Johnson B; Feeney D; Griffiths L; Shakib S; Brown G; Coulthard A; Mullins P; Kneebone C Mult Scler; 2009 Mar; 15(3):329-36. PubMed ID: 19039022 [TBL] [Abstract][Full Text] [Related]
68. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
69. Preemptive levetiracetam decreases postoperative pain in rats. Sliva J; Dolezal T; Prochazkova M; Votava M; Krsiak M Neuro Endocrinol Lett; 2008 Dec; 29(6):953-7. PubMed ID: 19112399 [TBL] [Abstract][Full Text] [Related]
70. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Bedlack RS; Pastula DM; Hawes J; Heydt D Amyotroph Lateral Scler; 2009 Aug; 10(4):210-5. PubMed ID: 18821142 [TBL] [Abstract][Full Text] [Related]
71. Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Meador KJ; Gevins A; Loring DW; McEvoy LK; Ray PG; Smith ME; Motamedi GK; Evans BM; Baum C Neurology; 2007 Nov; 69(22):2076-84. PubMed ID: 18040014 [TBL] [Abstract][Full Text] [Related]
72. Limited efficacy of levetiracetam on myoclonus of different etiologies. Lim LL; Ahmed A Parkinsonism Relat Disord; 2005 Mar; 11(2):135-7. PubMed ID: 15734675 [TBL] [Abstract][Full Text] [Related]
73. Response of infantile spasms to levetiracetam. Mikati MA; El Banna D; Sinno D; Mroueh S Neurology; 2008 Feb; 70(7):574-5. PubMed ID: 18268250 [No Abstract] [Full Text] [Related]
74. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers. Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136 [TBL] [Abstract][Full Text] [Related]
75. Tolerability and efficacy of oral loading of levetiracetam. Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995 [TBL] [Abstract][Full Text] [Related]
77. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693 [TBL] [Abstract][Full Text] [Related]
78. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus. Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418 [TBL] [Abstract][Full Text] [Related]
79. Positive and negative psychotropic effects of levetiracetam. Helmstaedter C; Fritz NE; Kockelmann E; Kosanetzky N; Elger CE Epilepsy Behav; 2008 Oct; 13(3):535-41. PubMed ID: 18583196 [TBL] [Abstract][Full Text] [Related]
80. Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report. Schroeder A; Linker RA; Lukas C; Kraus PH; Gold R Clin Neuropharmacol; 2010; 33(6):317-8. PubMed ID: 21079458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]